OMALIZUMAB IN TREATMENT FOR ALLERGIES
Omalizumab, whose active basis is recombinant, human, monoclonal antibodies to Ige, gives a unique therapeutic field in treatment for allergies. The present medication constitutes neutralizing antibodies, connecting Ige even before any appearance of allergic symptoms. A few years ago, omalizumab has...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Union of pediatricians of Russia,
2007-08-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|